|
|
||||||||
Eur J Cardiothorac Surg 2000;17:396-399
© 2000 Elsevier Science NL
Papworth Hospital, Cambridge CB3 8RE, UK
Corresponding author. Tel.: +44-1480-364299
e-mail: sam.nashef{at}papworth-tr.anglox.nhs.uk
| Abstract |
|---|
|
|
|---|
Key Words: Coronary surgery Europe European System for Cardiac Operative Risk Evaluation Epidemiology
| 1. Introduction |
|---|
|
|
|---|
| 2. Methods |
|---|
|
|
|---|
| 3. Results |
|---|
|
|
|---|
|
|
|
|
|
| 4. Discussion |
|---|
|
|
|---|
Many reasons can be put forward to account for the above differences. The epidemiology of ischaemic heart disease may differ significantly between countries. This may be related to hereditary factors, or to a variation in lifestyle and living standards with different diets, smoking history, alcohol consumption, and so on. Another reason may be found in the severity of cardiac disease and comorbidity in patients presenting for operation. This may be derived from differences in the risk profile of the population as a whole, or it may arise as a result of the impact of resource availability for coronary revascularization; the more limited the resources, the longer the waiting times and the more advanced the state of disease at the time of presentation to the surgeon. The UK, for example, has relatively fewer resources for coronary surgery in comparison with other northern European countries. It is interesting to note that surgery within 90 days of a myocardial infarct is relatively rare in the UK, presumably because of the more limited access to angiographic facilities. Finally, we highlighted differences which are likely to be more related to surgical decision making than to the risk profile of the patient, although the latter undoubtedly plays a part. Major differences in the use of the internal mammary artery as a conduit, in preoperative intra-aortic balloon use, and in the number of distal anastomoses are likely to be influenced by the prevalent surgical culture.
One interesting feature is the consistently higher risk profile on patients in some parts of southern Europe (France and Spain), and this is mirrored by a higher procedural mortality in coronary surgery. On the other hand, the exceptionally low surgical mortality rate in Finland is associated with a relatively low-risk cardiac surgical population as assessed by EuroSCORE.
Whatever the causes of the differences that we identified, it is clear that there is significant variation in patients, risk profile and surgical strategy in Europe. It is therefore not sufficient to assess the quality of care in European cardiac surgery by measuring crude procedural mortality alone.
One limitation of this study is the voluntary nature of centre recruitment in the EuroSCORE project. Such self-selection may introduce a bias towards centres that support open audit and assessment and, by implication, those whose results may better withstand close scrutiny. This limitation is partly addressed by the guaranteed patient, surgeon and centre confidentiality provided by the project organizers.
This study shows that international comparisons of operative mortality rates in Europe are meaningless without risk adjustments derived from casemix. The use of an appropriate risk stratification system which is compatible with European cardiac surgery would allow better comparison and more meaningful assessment of the quality of surgical care, provided that the system is applicable and has good discriminatory powers in individual European countries. Further analysis is needed to determine whether EuroSCORE satisfies these requirements.
| Footnotes |
|---|
| Appendix A. Conference discussion |
|---|
|
|
|---|
Dr Nashef: No, we haven't done that. It would be possible to do so, but we would also have to look at the resources and the availability of resources for coronary surgery, which are also different between countries.
Dr Pepper: Do you plan to do that?
Dr Nashef: Well, it is a little bit difficult, because although our samples represented a very large proportion of what happened in these countries during the three months, it was on a voluntary enrolment basis; for example, we have 100% of the operations in Scotland but only about 50 or 60% of the operations in Germany. So it would be a little bit difficult to carry out that sort of assessment.
Dr P. Sergeant (Leuven, Belgium): Could some of the differences be due to variable interpretation or to treatment variability?
Dr Nashef: I think it would be very difficult. If you saw the definitions that were given for the risk factors in the EuroSCORE data collection project, these definitions were very tight indeed, and the definitions were there at the point of data collection, so that it really allowed no ambiguity as to whether something would or would not feature as a factor.
Dr Sergeant: Has there been some active auditing or process control, validation after?
Dr Nashef: No. One of the limitations of this study is that there was no on-site validation, as you know.
Dr W. Brenner (Hackensack, NJ, USA): In the US, in the interest of consumer education, the publication of mortality data in newspapers and other media sources under the guise of allowing the consumers to make a better choice has resulted in denial of open heart surgery to high risk categories. As publication of data like this becomes more prevalent around the world, I am concerned that it becomes a game of gaming the system, comparing heterogeneous populations with homogenous populations. I wonder if we are really heading anywhere meaningful.
Dr Nashef: This is clearly one of the largest debates that we as cardiac surgeons will have to face in the next few years, and it has already happened in the US, it is beginning to happen in the UK, and I am sure that the rest of Europe will follow. I cannot really address that particular issue in this presentation, but it is important that, if we are going to risk-stratify, our system should be compatible with the population that we are looking at, and this issue will be dealt with by my collaborator on Wednesday.
Dr Sergeant: I think that the larger institutions in Europe, University Teaching Centers, or similar, should publish their risk profiles as well as their results. In our own institution, the average EuroSCORE predicted risk is 6%. Patient profiles can similarly vary from institution to institution as they vary between countries.
Dr R. Stanbridge (London, UK): I wondered if there was a sort of gross error check here, because I noticed that the figures for the UK for diabetes and hypertension seemed much lower than I would expect from our usual clinical practice, and I wondered if you had compared those figures with the practice that you have in Cambridge to see whether there is perhaps a big sampling error here or not?
Dr Nashef: The figures were compatible with what we have seen in Cambridge, and I think that perhaps if you look at your own figures you might find that they are not far off.
Dr F. Grover (Denver, CO, USA): This is really interesting data and it is interesting to see the different risk profiling from country to country. The US is more homogenous, I think, but then STS is also performing data analysis at some state and regional levels. We have found, in several, that our national risk coefficient is very close to regional risk coefficients, and can therefore be utilized for the state and regional analyses. There may be subtle differences in the prevalence of certain risk factors in different regions, but the weight of those risk factors on mortality may still be the same.
It would be interesting for you to calculate risk coefficients for each country eventually and do a risk algorithm for that country, utilize it for estimating the operative mortality using that risk algorithm, and then compare the results to those obtained from the risk coefficient that is derived from the data from all countries.
It may be that the single country and multi country risk models are very similar but the incidence of the various risk factors varies from country to country. The single risk coefficient may still produce an accurate estimate of your operative mortality. This is fascinating work and I appreciate your bringing it to our attention.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. H. Shuhaiber, K. Goldsmith, and S. A.M. Nashef Impact of cardiothoracic resident turnover on mortality after cardiac surgery: a dynamic human factor. Ann. Thorac. Surg., July 1, 2008; 86(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Poelaert, P. Depuydt, A. De Wolf, S. Van de Velde, I. Herck, and S. Blot Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: A pilot study. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 771 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Onorati, F. Pezzo, M. C. Comi, B. Impiombato, A. Esposito, M. Polistina, and A. Renzulli Radial artery graft function is not affected by age. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1112 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Biancari, O.-P. Kangasniemi, J. Luukkonen, S. Vuorisalo, J. Satta, R. Pokela, and T. Juvonen EuroSCORE predicts immediate and late outcome after coronary artery bypass surgery. Ann. Thorac. Surg., July 1, 2006; 82(1): 57 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson, L. Algotsson, P. Hoglund, C. Luhrs, and J. Brandt Comparison of 19 pre-operative risk stratification models in open-heart surgery Eur. Heart J., April 1, 2006; 27(7): 867 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kolh Importance of risk stratification models in cardiac surgery Eur. Heart J., April 1, 2006; 27(7): 768 - 769. [Full Text] [PDF] |
||||
![]() |
J.-S. Choi, K. R. Cho, and K.-B. Kim Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease? Ann. Thorac. Surg., October 1, 2005; 80(4): 1353 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Jarvinen, J. Julkunen, T. Saarinen, J. Laurikka, and M. R. Tarkka Effect of Diabetes on Outcome and Changes in Quality of Life After Coronary Artery Bypass Grafting Ann. Thorac. Surg., March 1, 2005; 79(3): 819 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karthik, A. K. Srinivasan, A. D. Grayson, M. Jackson, D. A.C. Sharpe, D. J.M. Keenan, B. Bridgewater, and B. M. Fabri Limitations of additive EuroSCORE for measuring risk stratified mortality in combined coronary and valve surgery{star} Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 318 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Al-Ruzzeh, G Asimakopoulos, G Ambler, R Omar, R Hasan, B Fabri, A El-Gamel, A DeSouza, V Zamvar, S Griffin, et al. Validation of four different risk stratification systems in patients undergoing off-pump coronary artery bypass surgery: a UK multicentre analysis of 2223 patients Heart, April 1, 2003; 89(4): 432 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Vroom Epidemiology and Pharmacotherapy of Acute Heart Failure Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 3 - 12. [PDF] |
||||
![]() |
M. Grimm, D. Zimpfer, M. Czerny, J. Kilo, M.-T. Kasimir, L. Kramer, A. Krokovay, and E. Wolner Neurocognitive deficit following mitral valve surgery Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 265 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Calafiore, M. Di Mauro, C. Canosa, G. Di Giammarco, A. L. Iaco, and M. Contini Early and late outcome of myocardial revascularization with and without cardiopulmonary bypass in high risk patients (EuroSCORE>=6) Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 360 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Petrou, F Roques, L D Sharples, R Kinsman, B Keogh, F Carey, and S A M Nashef The risk model of choice for coronary surgery in the UK Heart, January 1, 2003; 89(1): 98 - 99. [Full Text] [PDF] |
||||
![]() |
Z. Szabo, E. Hakanson, and R. Svedjeholm Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting Ann. Thorac. Surg., September 1, 2002; 74(3): 712 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zimpfer, M. Czerny, J. Kilo, M.-T. Kasimir, C. Madl, L. Kramer, G. M. Wieselthaler, E. Wolner, and M. Grimm Cognitive deficit after aortic valve replacement Ann. Thorac. Surg., August 1, 2002; 74(2): 407 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A.M. Nashef, F. Roques, B. G. Hammill, E. D. Peterson, P. Michel, F. L. Grover, R. K.H. Wyse, and T. B. Ferguson Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 101 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sergeant, E. de Worm, and B. Meyns Single centre, single domain validation of the EuroSCORE on a consecutive sample of primary and repeat CABG Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawachi, A. Nakashima, Y. Toshima, K. Arinaga, and H. Kawano Risk stratification analysis of operative mortality in heart and thoracic aorta surgery: comparison between Parsonnet and EuroSCORE additive model Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 961 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmitz and E. H. Blackstone International Council of Emboli Management (ICEM) Study Group results: risk adjusted outcomes in intraaortic filtration Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 986 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sergeant, E. de Worm, B. Meyns, and P. Wouters The challenge of departmental quality control in the reengineering towards off-pump coronary artery bypass grafting Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roques, S.A.M. Nashef, P. Michel, P. Pinna Pintor, M. David, E. Baudet, and The EuroSCORE Study Group Does EuroSCORE work in individual European countries? Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 27 - 30. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |